Top Markets
#1 Black Phoenix Black Phoenix +166.76%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +32.45%
#5 Cryptopia Cryptopia +21.67%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +18.20%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.17%
#9 DOVU DOVU +13.50%
#10 Test Test +13.48%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc.

ARYX
Rang in aandelen #41544
Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc.... Based in Fremont, California, and established in 1997, ARYx Therapeutics, Inc. is dedicated to discovering and advancing innovative treatments, primarily focusing on widespread, chronic conditions addressable with oral medications. The company utilizes its unique RetroMetabolic Drug Design technology to engineer distinctive molecular compounds that maintain the therapeutic effectiveness of their original counterparts. Its clinical development portfolio includes several promising candidates: Tecarfarin (ATI-5923): An oral anticoagulant currently in Phase III clinical trials, aimed at preventing hazardous blood clots in at-risk patients. Budiodarone (ATI-2042): An oral antiarrhythmic agent undergoing Phase IIb development for managing atrial fibrillation, a form of irregular heart rhythm. ATI-7505: An oral prokinetic agent in Phase IIb clinical development, targeting various gastrointestinal issues such as chronic constipation, gastroparesis, functional dyspepsia, irritable bowel syndrome with constipation, and gastroesophageal reflux disease. ATI-9242: An antipsychotic agent progressing through Phase I clinical trials for the treatment of schizophrenia and other psychiatric conditions. Additionally, ARYx Therapeutics is conducting early-stage research on ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal ailments.
Aandeelprijs
$0.0005
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$16.73K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel ARYx Therapeutics, Inc. (ARYX)

Categorie

Healthcare
Prijs ARYX met de marktkapitalisatie van B
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
ARYX
$0.0005
Marktkapitalisatie van ARYx Therapeutics, Inc.(ARYX)
Marktkapitalisatie: $16.73K
Vanaf August 2026 heeft ARYx Therapeutics, Inc. een marktkapitalisatie van $16.73K. Dit maakt ARYx Therapeutics, Inc. volgens onze gegevens het 41544th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van ARYx Therapeutics, Inc. van 2007 tot 2026
ARYX vergeleken met de top 5 populairste stocks
Prijs voor ARYX Aandeel B Marktkapitalisatie van B uitslagen
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$160,880 $16.73K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +32,175,957,463.80%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$132,191 $16.73K
Apple Inc. Apple Inc.
AAPL
$4.423T +26,438,295,302.18%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$124,331 $16.73K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +24,866,232,636.13%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$109,477 $16.73K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +21,895,408,644.25%
ARYx Therapeutics, Inc. ARYx Therapeutics, Inc.
$86,403.35 $16.73K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +17,280,669,288.56%